Literature DB >> 23099917

Ranibizumab for the management of Sorsby fundus dystrophy.

K Balaskas, M Hovan, S Mahmood, P Bishop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23099917      PMCID： PMC3545380          DOI： 10.1038/eye.2012.221

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide.

Authors:  Enrico Peiretti; James M Klancnik; Richard F Spaide; Lawrence Yannuzzi
Journal:  Retina       Date:  2005 Apr-May       Impact factor: 4.256

2.  Clinical course and treatment outcomes of Sorsby fundus dystrophy.

Authors:  Sobha Sivaprasad; Andrew R Webster; Catherine A Egan; Alan C Bird; Adnan Tufail
Journal:  Am J Ophthalmol       Date:  2008-05-23       Impact factor: 5.258

3.  Choroidal neovascularization secondary to Sorsby fundus dystrophy treated with systemic bevacizumab (Avastin).

Authors:  Franz Prager; Stephan Michels; Wolfgang Geitzenauer; Ursula Schmidt-Erfurth
Journal:  Acta Ophthalmol Scand       Date:  2007-04-13

4.  Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.

Authors:  B H Weber; G Vogt; R C Pruett; H Stöhr; U Felbor
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

5.  Recurrent choroidal neovascularization after laser photocoagulation in Sorsby's fundus dystrophy.

Authors:  F G Holz; R Haimovici; D G Wagner; A C Bird
Journal:  Retina       Date:  1994       Impact factor: 4.256
  5 in total
  5 in total

Review 1.  Sorsby fundus dystrophy: Insights from the past and looking to the future.

Authors:  Bela Anand-Apte; Jennifer R Chao; Ruchira Singh; Heidi Stöhr
Journal:  J Neurosci Res       Date:  2018-08-21       Impact factor: 4.164

Review 2.  Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options.

Authors:  Najiha Rahman; Michalis Georgiou; Kamron N Khan; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2019-11-08       Impact factor: 4.638

Review 3.  Sorsby fundus dystrophy (SFD): A narrative review.

Authors:  Georgios Tsokolas
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

Review 4.  Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby's Fundus Dystrophy: A Systematic Review.

Authors:  Arthur Baston; Christin Gerhardt; Souska Zandi; Justus G Garweg
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

Review 5.  Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy.

Authors:  Hanae C Y Gourier; N Victor Chong
Journal:  J Clin Med       Date:  2015-05-04       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.